VevaRX Tirzepatide Review: $467 per Three Months, Billed Once (2026)

VevaRX sells compounded tirzepatide only as a $467 three-month plan, billed once, with a three-month minimum, and automatic renewal every three months. No monthly option exists on its own product page, which is why we give the program no sortable monthly rate. Everything below was read live on 1 September 2026.¹

The $467, and the arithmetic printed beside it

The tirzepatide page prints "Equivalent to $149 per month" next to that total. Divided by three, $467 is $155.67 — which is exactly the figure VevaRX's own semaglutide page states, correctly, for the same $467. A $20 error over a quarter is small in money and large in what it says about the care taken with the copy. What the charge covers is at least stated plainly: the treatment, all the supplies and the provider visit, with free shipping in two to three days once a prescription is approved.

Where the site stops agreeing with itself

The FAQ enumerates 36 states by name rather than claiming the country, which is the better practice — and then the Terms claim twice that the products are available in all 50. Those same Terms name a different brand's domain as the one site transactions run on. The contact page's FAQ is another product's copy altogether: under the heading "How do I take Semaglutide or Tirzepatide?" it answers with instructions for mixing a scoop of powder into cold water. Three different return policies run across three surfaces, from a money-back guarantee to a flat refusal of returns once a compounded medication has shipped.

What the site never names

No pharmacy is named, no clinician is named, and no 503A or 503B designation appears anywhere. A census of all sixteen pages on 1 September found zero occurrences of either string. The Terms tell a patient with a question about preparation to contact the dispensing pharmacy directly, and the site never says which one that is. A full refund is offered where a provider disqualifies the patient; outside that case an order is non-refundable once the intake has been submitted.

The brand-vs-compounded question

This is compounded tirzepatide, and VevaRX says so, alongside a clear statement that it is not a pharmacy and neither compounds nor dispenses anything. Compounded drugs are pharmacy-made, are not FDA-approved finished products, and were not what the pivotal trials studied. Our guide to whether compounded tirzepatide is still legal in 2026 covers the position now that the shortage has ended.

How the care model holds up

The strengths are real: one all-in charge, free shipping, a state list given by name, and a refund where a provider says no. The weakness is that so much else on the site disagrees with something else on the site — prices, return policies, state coverage, even the brand named in the Terms. A quarterly commitment that renews on its own is a demanding thing to ask of a reader on that basis.

Does the drug work? (Separate from the provider)

The seller and the molecule earn their marks separately, and tirzepatide's are high. SURMOUNT-1 put average weight loss at roughly 15% to 21% of starting body weight over 72 weeks², and, head to head, SURMOUNT-5 beat semaglutide outright³. Both used the branded drug at approved doses rather than a compounded copy, a distinction our tirzepatide evidence guide works through.

The honest verdict

Judge this on the $467, and on nothing the page says about a monthly equivalent. If you would rather pay by the month and see a pharmacy named, AHBARx is $349 a month and names AnazaoHealth on its own pages. If the quarterly shape suits you but you want an entity and an address standing behind it, Andrew Meds publishes $299 a month and $797 for three, and names a legal entity with a Houston address. The rest of the field is ranked in our best tirzepatide providers list.